Sign inGet started

Hoekman John

Insider CIK 1855676 · IMPL Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IMPL IMPEL PHARMACEUTICALS INC A Award deriv2023-02-142023-02-1642,500— $042,500SEC↗
IMPL IMPEL NEUROPHARMA INC A Award deriv2022-01-262022-01-2835,000— $035,000SEC↗
IMPL IMPEL NEUROPHARMA INC M Exercise deriv2021-12-222021-12-2320,000— $00SEC↗
IMPL IMPEL NEUROPHARMA INC M Exercise2021-12-222021-12-2320,000$1.64 $32.8K128,221SEC↗
IMPL IMPEL NEUROPHARMA INC A Award deriv2021-07-202021-07-2650,000— $050,000SEC↗
IMPL IMPEL NEUROPHARMA INC C Conversion deriv2021-04-272021-04-2969,657— $00SEC↗
IMPL IMPEL NEUROPHARMA INC X Exercise deriv2021-04-272021-04-298,523$8.19 $69.8K0SEC↗
IMPL IMPEL NEUROPHARMA INC X Exercise deriv2021-04-272021-04-298,523— $069,657SEC↗
IMPL IMPEL NEUROPHARMA INC C Conversion deriv2021-04-272021-06-0769,657— $00SEC↗
IMPL IMPEL NEUROPHARMA INC C Conversion2021-04-272021-04-294,523— $0108,496SEC↗
IMPL IMPEL NEUROPHARMA INC J Other2021-04-272021-04-29275— $0108,221SEC↗
IMPL IMPEL NEUROPHARMA INC C Conversion2021-04-272021-06-074,253— $0108,496SEC↗